Physician

Ashok Mittal, MD

According to 2025 Medicare claims, Ashok Mittal, MD (NPI: 1164496055) practices pulmonary disease in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is ADVANCED LUNG AND SLEEP DISORDERS CONSULTANTS P A (NPI: 1023281060; TIN: 59-3532939) and primary practice location at 33709-1807.

Mittal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 476 traditional Medicare patients, billed 4,397 HCPCS/CPT codes, and received $555,581 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 6,818 prescription claims across 777 beneficiaries totaling $3,589,401 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 3,027 claims. Open Payments data shows 7 records totaling $131. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $767,806 to $555,581. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,056,317 to $3,589,401. For DME billing, this smaller-volume category changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	989	8,618	$767,806
2016	1,028	8,546	$745,781
2017	918	8,852	$1,040,245
2018	818	7,456	$680,330
2019	881	8,456	$756,212
2020	711	6,436	$577,569
2021	716	5,440	$505,683
2022	502	4,371	$454,705
2023	595	5,699	$664,155
2024	476	4,397	$555,581

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	794	7,715	$1,056,317
2016	865	7,845	$1,065,385
2017	863	7,605	$1,080,036
2018	784	6,623	$1,248,763
2019	807	6,887	$2,058,322
2020	854	7,286	$2,671,727
2021	913	7,788	$2,651,454
2022	827	7,228	$2,607,703
2023	861	7,145	$2,964,994
2024	777	6,818	$3,589,401

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,649	5,121	$318,327
2016	1,772	5,436	$348,743
2017	1,919	5,537	$352,217
2018	1,910	5,649	$368,932
2019	1,795	5,110	$311,590
2020	1,840	5,585	$384,720
2021	1,529	4,500	$299,636
2022	1,270	3,859	$251,051
2023	1,211	3,568	$194,429
2024	989	3,027	$189,308

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	161	1,486	$181
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	254	1,018	$146
94729	Test to examine how well the lungs exchange gases	146	155	$44
94727	Test to determine lung volumes using gas dilution or washout	146	155	$35
94060	Test to measure expiratory airflow and volume changes before and after medication administration	146	155	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	314	8,638	$1,189,082
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	962	35,124	$740,117
Xolair	Omalizumab	176	5,208	$696,629
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	276	9,960	$207,078
Dupixent Pen	Dupilumab	47	1,302	$176,267

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	12	58	$45,261
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	19	$17,912
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	15	$15,144
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	24	181	$12,492
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	43	211	$11,286

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$131	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ashok Mittal, MD?

Tedicare shows public-source Medicare data for Ashok Mittal, MD (NPI 1164496055), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashok Mittal, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ashok Mittal, MD?

Ashok Mittal, MD is linked to ADVANCED LUNG AND SLEEP DISORDERS CONSULTANTS P A (billing NPI 1023281060) in the available physician profile data.

Does Ashok Mittal, MD have Open Payments data?

Ashok Mittal, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.